News
As flowers bloom and temperatures climb, spring brings in allergy season for many. When sneezing, itchy eyes or sinus ...
Longitudinal evaluation of SNOT-22 can distinguish patients with chronic rhinosinusitis with nasal polyps who respond quickly ...
Top-line data from Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps expected in ...
Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.
The US regulator has asked for additional clinical data ... for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been shown to reduce symptoms. Sanofi/Regeneron's IL-4 and IL-13 ...
Notably, patients with nasal polyps experienced improvements in both symptoms and polyp size after ... LYRA), (“Lyra” or the “Company”), a clinical-stage biotechnology company developing ...
A careful history looking for the subtle symptoms of sinusitis ... and has proven useful to delineate the presence of nasal polyps (often hidden from anterior viewing), septal spurs, bifid ...
Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results